Breast Cancer Clinical Trial
Official title:
Improvement of Patient Experience and Healthcare Providers' Productivity Using Virtual Reality in the Field of Radiation Therapy
| Verified date | November 2020 |
| Source | Yonsei University |
| Contact | Yong Bae Kim |
| Phone | +82-2228-8095 |
| ybkim3[@]yuhs.ac | |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The purpose of this study is to investigate the effect of providing information about radiotherapy using virtual reality and to see whether it would improve the productivity of medical staff, improve patient experience and satisfaction, and reduce patient's anxiety prior to radiotherapy.
| Status | Recruiting |
| Enrollment | 196 |
| Est. completion date | October 2021 |
| Est. primary completion date | October 2021 |
| Accepts healthy volunteers | No |
| Gender | Female |
| Age group | 20 Years to 64 Years |
| Eligibility | Inclusion Criteria: 1. Breast cancer patients who received curative surgery and are planned to receive radiotherapy 2. Patients with cognitive abilities to receive virtual reality information 3. Patients who are 20 years old or older Exclusion Criteria: 1. Patients who have vision or hearing problems to receive information 2. Patients who do not agree to this study 3. Pregnancy, Fetuses / Newborns, Minors, and Deficient Patients 4. 65 years old or older 5. Patients who have been treated for dizziness within the last 6 months 6. Patients who have experienced severe dizziness within the last 6 months when using electronic devices |
| Country | Name | City | State |
|---|---|---|---|
| Korea, Republic of | Severance Hospital | Seoul | Korea |
| Lead Sponsor | Collaborator |
|---|---|
| Yonsei University |
Korea, Republic of,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Amsterdam Preoperative Anxiety and Information Scale (APAIS) | Changes in APAIS Before and After Providing Virtual Reality or Printed Document Information
- APAIS: scale from 1 (not worried at all) to 5 (extremely worried, most anxious) |
Prior to receiving the radiotherapy information via VR or printed document | |
| Primary | Amsterdam Preoperative Anxiety and Information Scale (APAIS) | Changes in APAIS Before and After Providing Virtual Reality or Printed Document Information
- APAIS: scale from 1 (not worried at all) to 5 (extremely worried, most anxious) |
5 minutes after receiving the radiotherapy information via VR or printed document | |
| Secondary | State-Trait Anxiety Inventory (STAI) | Changes in STAI Before and After Providing Virtual Reality or Printed Document Information | Prior to receiving the radiotherapy information via VR or printed document | |
| Secondary | State-Trait Anxiety Inventory (STAI) | Changes in STAI Before and After Providing Virtual Reality or Printed Document Information | 5 minutes after receiving the radiotherapy information via VR or printed document |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |